home All News open_in_new Full Article

Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium

Positions Curium as leading manufacturer of Lu-177 isotope Brings innovative R&D expertise and pipeline to Curium Enhances Curium’s SPECT & PET geographical coverage and supply chain PARIS, March 28, 2025 (GLOBE NEWSWIRE) — Curium Pharma (“Curium”), a world leader in nuclear medicine, is pleased to announce the completion of its acquisition of Eczacıbaşı-Monrol Nuclear Products […]


today 2 d. ago attach_file Culture

attach_file Economics
attach_file Events
attach_file Politics
attach_file Economics
attach_file Other
attach_file Other
attach_file Other
attach_file Politics
attach_file Society
attach_file Culture
attach_file Economics
attach_file Culture
attach_file Economics
attach_file Other
attach_file Society
attach_file Society
attach_file Other
attach_file Other
attach_file Politics
attach_file Transport


ID: 784586668
Add Watch Country

arrow_drop_down